Hypoparathyroidism cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
Irfan Dotani (talk | contribs) No edit summary |
m Bot: Removing from Primary care |
||
(4 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hypoparathyroidism}} | {{Hypoparathyroidism}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | |||
== | ==Future or Investigational Therapies== | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category: | {{WH}} | ||
{{WS}} | |||
[[Category:Disease]] | |||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Parathyroid disorders]] | |||
[[Category:Up-To-Date]] | |||
Latest revision as of 22:18, 29 July 2020
Hypoparathyroidism Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hypoparathyroidism cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Hypoparathyroidism cost-effectiveness of therapy |
Hypoparathyroidism cost-effectiveness of therapy in the news |
Risk calculators and risk factors for Hypoparathyroidism cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: